BackCelyad Oncology Overview

Celyad Oncology Research & Development

Research & Development expenses for CYAD.

Quarterly R&D Expenses

$1.78M
↓ 29.77% YoY

As of Dec 31, 2024

Annual R&D Expenses (TTM)

$7.61M
↓ 140.23% YoY

Trailing 12 months ending Dec 31, 2024

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin